Here, we explore the potential association of the neurodegenerative proteins α-synuclein, beta-amyloid (Aβ), and tau with epilepsy, based on previous clinical and pre-clinical experimental studies [25,26,27,28,29,30], and highlight a novel avenue for research with potential therapeutic targets. This evidence concerns the gene SNCA and epilepsy.